Stay updated on Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial
Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.

Latest updates to the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page's navigation and guidance sections were updated to include new items such as 'No longer looking for participants', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The Intervention / Treatment heading formatting was changed to 'Intervention/Treatment' and the revision label updated from v3.5.5 to v3.6.0, indicating a UI revision rather than data changes.SummaryDifference0.4%

- Check16 days agoChange DetectedThe page revision indicator was updated from v3.5.4 to v3.5.5, signaling a new version of the page without changes to study details or results.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page’s software revision has been updated from v3.5.3 to v3.5.4. This represents an incremental platform update rather than a modification to the study information presented on the page.SummaryDifference0.1%

- Check59 days agoChange DetectedClinicalTrials.gov’s page revision/version label was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check96 days agoChange DetectedRevision: v3.5.0 is now displayed on the page, replacing Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.